Health-related quality of life after IMRT or IMRT+ HDR brachytherapy for intermediate or high-risk prostate cancer: Five-year results of a prospective trial. This is an ASCO Meeting Abstract from the ...
An automated bone scan algorithm has shown its value in determining the response to radium-223 (Ra-223) treatment for patients with metastatic castration-resistant prostate cancer (mCRPC), according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback